Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 10881 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Nordic Bioscience to make its precision medicine biomarker PRO-C3 available in China for research use only (RUO) in the first quarter of 2024.

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024

GSK's Maria Reyes Boceta-Muñoz Talks Vaccine Development and Vaccine Clinical Trials in a Post-Pandemic World, Featured Interview by Xtalks

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024
Related companies:  Xtalks

BioXcel Therapeutics Announces USPTO’s Allowance of Patent Application for Method of Treating Agitation in Alzheimer’s Disease Using Oromucosal Formulations of Dexmedetomidine

Read more ››
By: GlobeNewswire - 05 Feb 2024
Related companies:  BioXcel Therapeutics, Inc.

FibroGen To Host Part I of Virtual KOL Investor Event Series to Review Pamrevlumab Clinical Program in Pancreatic Cancer on February 13, 2024

Read more ››
By: GlobeNewswire - 05 Feb 2024
Related companies:  FibroGen, Inc.

BioCryst to Present New ORLADEYO® (berotralstat) Real-world Data at 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting

Read more ››
By: GlobeNewswire - 05 Feb 2024
Related companies:  BioCryst Pharmaceuticals, Inc.

Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments

Read more ››
By: GlobeNewswire - 05 Feb 2024
Related companies:  Lexeo Therapeutics, Inc.

Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference

Read more ››
By: GlobeNewswire - 05 Feb 2024
Related companies:  Achilles Therapeutics plc

Memo Therapeutics AG Strengthens Management Team

Read more ››
By: GlobeNewswire - 05 Feb 2024
Related companies:  Memo Therapeutics AG

Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome

Read more ››
By: GlobeNewswire - 05 Feb 2024
Related companies:  Orchard Therapeutics plc

BridgeBio Pharma Announces U.S. Food and Drug Administration (FDA) Acceptance of New Drug Application (NDA) for Acoramidis for the Treatment of Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Read more ››
By: GlobeNewswire - 05 Feb 2024
Related companies:  BridgeBio Pharma, Inc.

Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

Read more ››
By: GlobeNewswire - 05 Feb 2024
Related companies:  Microbot Medical Inc.

Verrica Pharmaceuticals Files Lawsuit Against Canadian Drug Manufacturer for False Advertising and Unfair Competition

Read more ››
By: GlobeNewswire - 05 Feb 2024
Related companies:  Verrica Pharmaceuticals Inc.

Spectral Medical Provides Early February Tigris Trial Update

Read more ››
By: GlobeNewswire - 05 Feb 2024
Related companies:  Spectral Medical Inc.

Aurora Spine’s Second Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent Office

Read more ››
By: GlobeNewswire - 05 Feb 2024
Related companies:  Aurora Spine Corporation

BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease

Read more ››
By: GlobeNewswire - 05 Feb 2024
Related companies:  BioRestorative Therapies, Inc.

One World Products Confirms That Its Colombian Cannabis Operations are Unaffected by Recent Regulatory Developments in Colombia

Read more ››
By: GlobeNewswire - 05 Feb 2024

Adverum Biotechnologies Announces $127.5 Million Private Placement Financing

Read more ››
By: GlobeNewswire - 05 Feb 2024
Related companies:  Adverum Biotechnologies, Inc.

Avicanna Announces Supply and Licensing Agreement with Multinational Pharmaceutical Company

Read more ››
By: GlobeNewswire - 05 Feb 2024
Related companies:  Avicanna Inc.

Clearmind Medicine Receives Patent Approval for its Psychedelic Based Treatment of Binge Behaviors in China

Read more ››
By: GlobeNewswire - 05 Feb 2024
Related companies:  Clearmind Medicine Inc.

Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111)

Read more ››
By: GlobeNewswire - 05 Feb 2024
Related companies:  Rani Therapeutics, LLC
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑